Wordt geladen...
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
Down syndrome (DS) is one of the leading causes of intellectual disability, and patients with DS face various health issues, including learning and memory deficits, congenital heart disease, Alzheimer’s disease (AD), leukemia, and cancer, leading to huge medical and social costs. Remarkable advances...
Bewaard in:
| Gepubliceerd in: | Front Behav Neurosci |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4891327/ https://ncbi.nlm.nih.gov/pubmed/27375444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnbeh.2016.00104 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|